-
1دورية أكاديميةPhase II Trial of IL-12 Plasmid Transfection and PD-1 Blockade in Immunologically Quiescent Melanoma
المؤلفون: Algazi, Alain P, Twitty, Christopher G, Tsai, Katy K, Le, Mai, Pierce, Robert, Browning, Erica, Hermiz, Reneta, Canton, David A, Bannavong, Donna, Oglesby, Arielle, Francisco, Murray, Fong, Lawrence, Pittet, Mikael J, Arlauckas, Sean P, Garris, Christopher, Levine, Lauren P, Bifulco, Carlos, Ballesteros-Merino, Carmen, Bhatia, Shailender, Gargosky, Sharron, Andtbacka, Robert HI, Fox, Bernard A, Rosenblum, Michael D, Daud, Adil I
المصدر: Clinical Cancer Research. 26(12)
مصطلحات موضوعية: Clinical Research, Cancer, Clinical Trials and Supportive Activities, Adult, Aged, Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols, Case-Control Studies, Female, Follow-Up Studies, Humans, Interleukin-12, Male, Melanoma, Middle Aged, Prognosis, Programmed Cell Death 1 Receptor, Prospective Studies, Oncology and Carcinogenesis, Oncology & Carcinogenesis
وصف الملف: application/pdf
الوصول الحر: https://escholarship.org/uc/item/59t2b8v3Test
-
2دورية أكاديمية
المؤلفون: Pai, Chien-Chun Steven, Huang, John T, Lu, Xiaoqing, Simons, Donald M, Park, Chanhyuk, Chang, Anthony, Tamaki, Whitney, Liu, Eric, Roybal, Kole T, Seagal, Jane, Chen, Mingyi, Hagihara, Katsunobu, Wei, Xiao X, DuPage, Michel, Kwek, Serena S, Oh, David Y, Daud, Adil, Tsai, Katy K, Wu, Clint, Zhang, Li, Fasso, Marcella, Sachidanandam, Ravi, Jayaprakash, Anitha, Lin, Ingrid, Casbon, Amy-Jo, Kinsbury, Gillian A, Fong, Lawrence
المصدر: Immunity. 50(2)
مصطلحات موضوعية: T-Lymphocytes, Cell Line, Tumor, Animals, Mice, Inbred C57BL, Mice, Knockout, Humans, Neoplasms, Experimental, Antibodies, Monoclonal, Tumor Burden, Clonal Deletion, Drug Resistance, Neoplasm, Male, Interferon-gamma, CTLA-4 Antigen, Programmed Cell Death 1 Receptor, IFN-γ, activation-induced cell death, anti-CTLA-4, anti-PD-1, cancer, immunotherapy, Immunization, Cancer, Vaccine Related, Development of treatments and therapeutic interventions, 5.1 Pharmaceuticals, Inflammatory and immune system, Immunology
وصف الملف: application/pdf
الوصول الحر: https://escholarship.org/uc/item/3vt866nqTest
-
3دورية أكاديمية
المؤلفون: Tumeh, Paul C, Hellmann, Matthew D, Hamid, Omid, Tsai, Katy K, Loo, Kimberly L, Gubens, Matthew A, Rosenblum, Michael, Harview, Christina L, Taube, Janis M, Handley, Nathan, Khurana, Neharika, Nosrati, Adi, Krummel, Matthew F, Tucker, Andrew, Sosa, Eduardo V, Sanchez, Phillip J, Banayan, Nooriel, Osorio, Juan C, Nguyen-Kim, Dan L, Chang, Jeremy, Shintaku, I Peter, Boasberg, Peter D, Taylor, Emma J, Munster, Pamela N, Algazi, Alain P, Chmielowski, Bartosz, Dummer, Reinhard, Grogan, Tristan R, Elashoff, David, Hwang, Jimmy, Goldinger, Simone M, Garon, Edward B, Pierce, Robert H, Daud, Adil
المصدر: Cancer Immunology Research. 5(5)
مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Immunology, Digestive Diseases, Clinical Research, Cancer, Lung, Lung Cancer, Liver Disease, Adult, Aged, Aged, 80 and over, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Immunological, CD8-Positive T-Lymphocytes, Carcinoma, Non-Small-Cell Lung, Disease-Free Survival, Female, Humans, Kaplan-Meier Estimate, Liver Neoplasms, Lung Neoplasms, Lymphocytes, Tumor-Infiltrating, Male, Melanoma, Middle Aged, Programmed Cell Death 1 Receptor, Treatment Outcome, Young Adult, Pharmacology and Pharmaceutical Sciences, Oncology and carcinogenesis
وصف الملف: application/pdf
الوصول الحر: https://escholarship.org/uc/item/6qg0w4snTest
-
4دورية أكاديمية
المؤلفون: Nosrati, Adi, Tsai, Katy K, Goldinger, Simone M, Tumeh, Paul, Grimes, Barbara, Loo, Kimberly, Algazi, Alain P, Nguyen-Kim, Thi Dan Linh, Levesque, Mitchell, Dummer, Reinhard, Hamid, Omid, Daud, Adil
المصدر: British Journal of Cancer. 116(9)
مصطلحات موضوعية: Cancer, Detection, screening and diagnosis, 4.2 Evaluation of markers and technologies, Age Factors, Aged, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Female, Gene Expression Regulation, Neoplastic, Humans, Immunotherapy, Ipilimumab, L-Lactate Dehydrogenase, Male, Melanoma, Middle Aged, Neoplasm Staging, Nivolumab, Prognosis, Programmed Cell Death 1 Receptor, immunotherapy, pembrolizumab, nivolumab, advanced melanoma, prediction scale, Oncology and Carcinogenesis, Public Health and Health Services, Oncology & Carcinogenesis
وصف الملف: application/pdf
الوصول الحر: https://escholarship.org/uc/item/8w50t9twTest
-
5دورية أكاديمية
المؤلفون: Algazi, Alain P, Tsai, Katy K, Shoushtari, Alexander N, Munhoz, Rodrigo R, Eroglu, Zeynep, Piulats, Josep M, Ott, Patrick A, Johnson, Douglas B, Hwang, Jimmy, Daud, Adil I, Sosman, Jeffrey A, Carvajal, Richard D, Chmielowski, Bartosz, Postow, Michael A, Weber, Jeffrey S, Sullivan, Ryan J
المصدر: Cancer. 122(21)
مصطلحات موضوعية: Prevention, Rare Diseases, Clinical Research, Cancer, Clinical Trials and Supportive Activities, Evaluation of treatments and therapeutic interventions, 6.2 Cellular and gene therapies, 6.1 Pharmaceuticals, Adult, Aged, Aged, 80 and over, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols, B7-H1 Antigen, Female, Follow-Up Studies, Humans, Male, Melanoma, Middle Aged, Mucous Membrane, Neoplasm Staging, Nivolumab, Prognosis, Programmed Cell Death 1 Receptor, Retrospective Studies, Skin Neoplasms, Survival Rate, Uveal Neoplasms, atezolizumab, immunotherapy, nivolumab, pembrolizumab, uveal melanoma, Oncology and Carcinogenesis, Public Health and Health Services, Oncology & Carcinogenesis
وصف الملف: application/pdf
الوصول الحر: https://escholarship.org/uc/item/9vf0j5s5Test
-
6دورية أكاديمية
المؤلفون: Shoushtari, Alexander N, Munhoz, Rodrigo R, Kuk, Deborah, Ott, Patrick A, Johnson, Douglas B, Tsai, Katy K, Rapisuwon, Suthee, Eroglu, Zeynep, Sullivan, Ryan J, Luke, Jason J, Gangadhar, Tara C, Salama, April KS, Clark, Varina, Burias, Clare, Puzanov, Igor, Atkins, Michael B, Algazi, Alain P, Ribas, Antoni, Wolchok, Jedd D, Postow, Michael A
المصدر: Cancer. 122(21)
مصطلحات موضوعية: Clinical Trials and Supportive Activities, Cancer, Clinical Research, Adult, Aged, Aged, 80 and over, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols, Brain Neoplasms, Female, Follow-Up Studies, Humans, Liver Neoplasms, Male, Melanoma, Middle Aged, Mucous Membrane, Neoplasm Staging, Nivolumab, Prognosis, Programmed Cell Death 1 Receptor, Retrospective Studies, Skin Neoplasms, Survival Rate, acral melanoma, anti-programmed cell death receptor 1, immunotherapy, mucosal melanoma, nivolumab, pembrolizumab, Oncology and Carcinogenesis, Public Health and Health Services, Oncology & Carcinogenesis
وصف الملف: application/pdf
الوصول الحر: https://escholarship.org/uc/item/2fv7q2d5Test
-
7دورية أكاديمية
المؤلفون: Tsai, Katy K, Daud, Adil I
المصدر: Journal of Hematology & Oncology. 8(1)
مصطلحات موضوعية: Immunization, Cancer, Antibodies, Monoclonal, Antineoplastic Combined Chemotherapy Protocols, Clinical Trials, Phase III as Topic, Disease-Free Survival, Double-Blind Method, Drug Administration Schedule, Follow-Up Studies, Humans, Ipilimumab, Melanoma, Multicenter Studies as Topic, Nivolumab, Randomized Controlled Trials as Topic, Skin Neoplasms, Treatment Outcome, Immunotherapy, PD-1, CTLA-4, Cardiorespiratory Medicine and Haematology, Oncology and Carcinogenesis
وصف الملف: application/pdf
الوصول الحر: https://escholarship.org/uc/item/18s7b110Test
-
8دورية أكاديمية
المؤلفون: Tsai, Katy K, Zarzoso, Inés, Daud, Adil I
المصدر: Human Vaccines & Immunotherapeutics. 10(11)
مصطلحات موضوعية: Cancer, Immunization, Climate-Related Exposures and Conditions, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, B7-H1 Antigen, CTLA-4 Antigen, Humans, Immunotherapy, Lymphocyte Activation, Melanoma, Nivolumab, Programmed Cell Death 1 Receptor, T-Lymphocytes, BMS-936559, PD-1, PD-L1, PD-L2, immunotherapy, MPDL3280A, melanoma, nivolumab, pembrolizumab, AE, adverse event, APC, antigen presenting cell, ASCO, American Society of Clinical Oncology, CTLA-4, cytotoxic T-lymphocyte-associated protein 4, FDA, Food and Drug Administration, gp100, glycoprotein 100 vaccine, Ig, immunoglobulin, ITIM, immunoreceptor tyrosine-based inhibitory motif, ITSM, immunoreceptor tyrosine-based switch motif, MAPK, mitogen-activated protein kinase, MHC, major histocompatibility complex, NK, natural killer, ORR, objective response rate, OS, overall survival, PD, progressive disease, programmed cell death 1, programmed cell death ligand 1, PFS, progression free survival, TCR, T cell receptor, TIL, tumor infiltrating lymphocyte, AE, adverse event, APC, antigen presenting cell, ASCO, American Society of Clinical Oncology, CTLA-4, cytotoxic T-lymphocyte-associated protein 4, FDA, Food and Drug Administration, ITIM, immunoreceptor tyrosine-based inhibitory motif, ITSM, immunoreceptor tyrosine-based switch motif, Ig, immunoglobulin, MAPK, mitogen-activated protein kinase, MHC, major histocompatibility complex, NK, natural killer, ORR, objective response rate, OS, overall survival, PD, progressive disease, PD-1, programmed cell death 1, PD-L1, programmed cell death ligand 1, PFS, progression free survival, TCR, T cell receptor, TIL, tumor infiltrating lymphocyte, gp100, glycoprotein 100 vaccine, Immunology, Medical Microbiology, Pharmacology and Pharmaceutical Sciences, Virology
وصف الملف: application/pdf
الوصول الحر: https://escholarship.org/uc/item/49q8w2djTest